Innovacell - Biotechnologie


Business Strategy

Innovacell is focussed on completing the clinical testing of ICES13, followed by obtaining permission for it to be internationally marketed. At the same time, Innovacell is working on the clinical development of ICEF15. Innovacell plans to market and distribute its products itself within the EU or, in the case of ICEF15, with the cooperation of its partner Norgine. The introduction of products onto the global market and worldwide distribution could be handled by licensing partners.